E-LIB Suche - Ergebnisse für: Ahn, Inhye E.

1

Five-year follow-up of a phase 2 study of ibrutinib plus fl..:

Ahn, Inhye E. ; Brander, Danielle M. ; Ren, Yue...
Blood Advances. 8 (2024) 4 - p. 832-841 , 2024

Link: https://doi.org/10.1182/..

2

Masked Arginine Vasopressin Deficiency (AVP-D) in a Kidney ..:

Liu, Annie ; Nayak, Lakshmi ; Wong, Waihay J...
Kidney International Reports. , 2024

Link: https://doi.org/10.1016/..

3

Therapeutic targeting of apoptosis in chronic lymphocytic l..:

Ahn, Inhye E. ; Davids, Matthew S.
Seminars in Hematology. 61 (2024) 2 - p. 109-118 , 2024

Link: https://doi.org/10.1053/..

4

A multi-cohort phase 1b trial of rituximab in combination w..:

Merryman, Reid W. ; Redd, Robert A. ; Freedman, Arnold S....
Annals of Hematology. , 2023

Link: https://doi.org/10.1007/..

5

Interim Positron Emission Tomography During Frontline Chemo..:

Merryman, Reid W. ; Michaud, Laure ; Redd, Robert...
HemaSphere. 7 (2023) 2 - p. e826 , 2023

Link: https://doi.org/10.1097/..

6

Cytotoxicity of the CD3×CD20 bispecific antibody epcoritama..:

Mhibik, Maissa ; Gaglione, Erika M. ; Eik, David...
Blood Advances. 7 (2023) 15 - p. 4089-4101 , 2023

Link: https://doi.org/10.1182/..

7

B-cell Receptor Pathway Mutations Are Infrequent in Patient..:

Woyach, Jennifer A. ; Ghia, Paolo ; Byrd, John C....
Clinical Cancer Research. 29 (2023) 16 - p. 3065-3073 , 2023

Link: https://doi.org/10.1158/..

8

Characteristics and Clinical Outcomes of Patients with Chro..:

Woyach, Jennifer A. ; Barr, Paul M. ; Kipps, Thomas J....
Cancers. 15 (2023) 2 - p. 507 , 2023

Link: https://doi.org/10.3390/..

9

BTK inhibitors impair humoral and cellular responses to rec..:

Pleyer, Christopher ; Laing, Kerry J. ; Ali, Mir A....
Blood Advances. 6 (2022) 6 - p. 1732-1740 , 2022

Link: https://doi.org/10.1182/..

10

CLL-418 Characteristics and Clinical Outcomes of Patients W..:

Woyach, Jennifer A. ; Barr, Paul M. ; Kipps, Thomas J....
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S278 , 2022

Link: https://doi.org/10.1016/..

11

Poster: CLL-418 Characteristics and Clinical Outcomes of Pa..:

Woyach, Jennifer A. ; Barr, Paul M. ; Kipps, Thomas J....
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S140 , 2022

Link: https://doi.org/10.1016/..

12

Old Prognostic Markers Still Have a Role in CLL Management:

Ahn, Inhye E.
Clinical Lymphoma Myeloma and Leukemia. 21 (2021) - p. S139-S141 , 2021

Link: https://doi.org/10.1016/..

13

Targeting Bruton's Tyrosine Kinase in CLL:

Ahn, Inhye E. ; Brown, Jennifer R.
Frontiers in Immunology. 12 (2021) - p. , 2021

Link: https://doi.org/10.3389/..

14

Long‐term efficacy of first‐line ibrutinib treatment for ch..:

Allan, John N. ; Shanafelt, Tait ; Wiestner, Adrian...
British Journal of Haematology. 196 (2021) 4 - p. 947-953 , 2021

Link: https://doi.org/10.1111/..

15

A phase II study of ibrutinib and short‐course fludarabine ..:

Pleyer, Christopher ; Tian, Xin ; Rampertaap, Shakuntala...
American Journal of Hematology. 95 (2020) 11 - p. , 2020

Link: https://doi.org/10.1002/..